Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwMyeloma 2022 | Novel targets in 2022

In this discussion, the experts discuss IMiD resistance, immunogenic cell death, novel approaches to amyloidosis, as well as approaching a cure. Faith Davies, MBBCh, MRCP, MD, FRCPath, of NYU Langone Medical Center, New York, NY, chairs this session with Charlotte Pawlyn, BA, MBBChir, MRCP, PhD, FRCPath, of The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK and Hearn Jay Cho, MD, PhD, of Mount Sinai Hospital, New York, NY. This discussion took place at The International Workshop on Myeloma 2022, held in Scottsdale, AZ.